Last week, Amyris Biotechnologies raised $84.8 million in its initial public offering (IPO), below its target of $100 million. At week's end, the stock was trading at about $17 a...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 (0) 20-3460840
For APAC (Singapore)